Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
Exelixis (Nasdaq: EXEL) announced its participation in the William Blair 44th Annual Growth Stock Conference. The company will present a fireside chat on June 4 at 4:20 p.m. ET in Chicago.
The event will be webcast live on the company’s website, www.exelixis.com, and a replay will be available for at least 30 days post-event.
- Exelixis is participating in a high-profile investor conference, which can enhance visibility and investor interest.
- The event will be webcast, allowing wider access and engagement from global investors.
- The announcement does not include any new financial or clinical data, which may not significantly impact the stock price.
- No specific strategic updates or advancements were mentioned, potentially limiting immediate investor enthusiasm.
– Presentation to be webcast on www.exelixis.com –
To access the webcast link, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. A replay will also be available at the same location for at least 30 days.
About Exelixis
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are registered
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528802316/en/
Investors Contact:
Varant Shirvanian
Director, Investor Relations
Exelixis, Inc.
650-837-7917
vshirvanian@exelixis.com
Media Contact:
Hal Mackins
For Exelixis, Inc.
415-994-0040
hal@torchcommunications.com
Source: Exelixis, Inc.
FAQ
When will Exelixis present at the William Blair 44th Annual Growth Stock Conference?
How can I access the Exelixis webcast of the William Blair conference?
Will there be a replay available for Exelixis's presentation at the William Blair conference?
